Fate Therapeutics (FATE) EPS (Basic) (2012 - 2026)
Fate Therapeutics' (FATE) quarterly EPS (Basic) came in at -$1.23 in Q1 2026, up 13.22% YoY from -$1.09 in Q1 2025, and down 349.8% on a QoQ basis from -$0.27 in Q4 2025.
Fate Therapeutics (FATE) EPS (Basic) (2012 - 2026) Analysis & Trends
Fate Therapeutics (FATE) has 15 years of EPS (Basic) data on file, last reported at -$1.23 in Q1 2026.
- Quarterly EPS (Basic) rose 13.22% year-over-year to -$1.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 (up 69.87% YoY) and the FY2025 annual result came in at -$4.42, up 9.54% from the prior year.
- EPS (Basic) fell to -$1.23 in Q1 2026, from -$0.27 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.27 in Q4 2025 to a low of -$3.74 in Q4 2023.
- A 5-year average of -$1.71 and a median of -$1.42 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 105.16% — and 2025, when it jumped 92.59%.
- Tracing FATE's EPS (Basic) over 5 years: stood at -$3.7 in 2022, then dropped by 1.09% to -$3.74 in 2023, then grew by 1.11% to -$3.69 in 2024, then jumped by 92.59% to -$0.27 in 2025, then sank by 349.8% to -$1.23 in 2026.
- The last three EPS (Basic) figures came in at -$1.23 (Q1 2026), -$0.27 (Q4 2025), and -$0.63 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - | -1.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.23 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.63 |
| Jun 30, 2025 | -0.38 |
| Mar 31, 2025 | -1.42 |
| Dec 31, 2024 | -3.69 |
| Sep 30, 2024 | -1.70 |
| Jun 30, 2024 | -1.67 |
| Mar 31, 2024 | -1.03 |
| Dec 31, 2023 | -3.74 |
| Sep 30, 2023 | -2.16 |
| Jun 30, 2023 | -1.24 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -3.70 |
| Sep 30, 2022 | -1.60 |
| Jun 30, 2022 | -2.77 |
| Mar 31, 2022 | -0.93 |
| Dec 31, 2021 | -3.12 |
| Sep 30, 2021 | -2.54 |
| Jun 30, 2021 | -1.35 |